Serial physical examination to reduce unnecessary antibiotic exposure in newborn infants: a population-based study

Anlaug Vatne1, Beate Horsberg Horsberg Eriksen2,3, Fabian Bergqvist4

  • 1Department of Pediatrics, Stavanger University Hospital, Stavanger, Norway anlaug.vatne@sus.no.

Insights

Serial physical examination (SPE) safely reduced early antibiotic exposure by 50% in infants at risk for early onset sepsis (EOS) without impacting safety outcomes. This approach aids in judicious antibiotic use in neonatal intensive care units (NICUs).

Area of Science:

  • Neonatal Medicine
  • Pediatric Infectious Diseases
  • Clinical Pharmacology

Background:

  • Antibiotic overuse in neonatal intensive care units (NICUs) for infants at risk of early onset sepsis (EOS) poses challenges.
  • Diagnostic uncertainty leads to unnecessary antibiotic exposure in up to 12.0% of non-infected infants.
  • Developing safe, effective strategies to reduce early antibiotic exposure is critical.

Purpose of the Study:

  • To evaluate the safety and efficacy of serial physical examination (SPE) in reducing early antibiotic exposure in infants at risk for EOS.
  • To assess the impact of SPE on key safety outcomes, including incidence of EOS and infection-related adverse events.

Main Methods:

  • A population-based, multicentre interventional study conducted in six Norwegian NICUs from 2018 to 2021.
  • Inclusion of 54,713 liveborn infants born at or after 34 weeks' gestation at risk for EOS.
  • Implementation of a 24-48 hour SPE protocol for clinical monitoring, guiding antibiotic initiation based on clinical signs and stability.

Main Results:

  • Antibiotic exposure in infants at risk for EOS was reduced by 50%, from 1.8% to 0.9%.
  • The incidence of culture-positive EOS, NICU admission rates, and overall safety outcomes remained unchanged.
  • No significant differences were observed in time to antibiotic administration for confirmed EOS or infection-related re-admissions.

Conclusions:

  • Serial physical examination (SPE) is a safe and effective strategy for reducing unnecessary antibiotic exposure in infants at risk for early onset sepsis (EOS).
  • This approach allows for judicious antibiotic use in neonatal intensive care units (NICUs) without compromising patient safety.
  • SPE supports evidence-based clinical decision-making in neonatal sepsis management.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.6K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
235
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
232
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
179